227 related articles for article (PubMed ID: 35541032)
1. Immunocytochemistry of effusion fluids: Introduction to SCIP approach.
Shidham VB; Layfield LJ
Cytojournal; 2022; 19():3. PubMed ID: 35541032
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemistry of effusions: Processing and commonly used immunomarkers.
Shidham VB; Janikowski B
Cytojournal; 2022; 19():6. PubMed ID: 35541029
[TBL] [Abstract][Full Text] [Related]
3. Approach to Diagnostic Cytopathology of Serous Effusions.
Shidham VB; Layfield LJ
Cytojournal; 2021; 18():32. PubMed ID: 35126610
[TBL] [Abstract][Full Text] [Related]
4. Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology?
Lyons-Boudreaux V; Mody DR; Zhai J; Coffey D
Arch Pathol Lab Med; 2008 Jan; 132(1):23-8. PubMed ID: 18181669
[TBL] [Abstract][Full Text] [Related]
5. Cell-blocks and immunohistochemistry.
Shidham VB; Layfield LJ
Cytojournal; 2021; 18():2. PubMed ID: 33598043
[TBL] [Abstract][Full Text] [Related]
6. Two-color immunocytochemistry for evaluation of effusion fluids for metastatic adenocarcinoma.
Shidham VB; Varsegi G; D'Amore K
Cytojournal; 2010 Feb; 7():1. PubMed ID: 20333313
[TBL] [Abstract][Full Text] [Related]
7. Introduction to the second edition of 'Diagnostic Cytopathology of Serous Fluids' as CytoJournal Monograph (CMAS) in Open Access.
Shidham VB; Layfield LJ
Cytojournal; 2021; 18():30. PubMed ID: 35126608
[TBL] [Abstract][Full Text] [Related]
8. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
9. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA
Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174
[TBL] [Abstract][Full Text] [Related]
10. MOC-31 aids in the differentiation between adenocarcinoma and reactive mesothelial cells.
Morgan RL; De Young BR; McGaughy VR; Niemann TH
Cancer; 1999 Dec; 87(6):390-4. PubMed ID: 10603193
[TBL] [Abstract][Full Text] [Related]
11. The impact of different fixatives on immunostaining of lung adenocarcinomas in pleural effusion cell blocks.
Mansour MSI; Pettersson L; Seidal T; Strömberg U; Mager U; Ali L; Kumbaric S; Hejny K; Taheri-Eilagh F; Mufti J; Nakdali D; Brunnström H
Cancer Cytopathol; 2024 Jun; ():. PubMed ID: 38829774
[TBL] [Abstract][Full Text] [Related]
12. CellBlockistry: Chemistry and art of cell-block making - A detailed review of various historical options with recent advances.
Shidham VB
Cytojournal; 2019; 16():12. PubMed ID: 31367220
[TBL] [Abstract][Full Text] [Related]
13. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
[TBL] [Abstract][Full Text] [Related]
14. IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology.
Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
Hum Pathol; 2010 May; 41(5):745-50. PubMed ID: 20060157
[TBL] [Abstract][Full Text] [Related]
15. Collection and processing of effusion fluids for cytopathologic evaluation.
Shidham VB
Cytojournal; 2022; 19():5. PubMed ID: 35541031
[TBL] [Abstract][Full Text] [Related]
16. Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.
Capkova L; Koubkova L; Kodet R
Neoplasma; 2014; 61(2):161-9. PubMed ID: 24471939
[TBL] [Abstract][Full Text] [Related]
17. Absence of SV-40 large T antigen (Tag) in malignant mesothelioma effusions: an immunocytochemical study.
Simsir A; Fetsch P; Bedrossian CW; Ioffe OB; Abati A
Diagn Cytopathol; 2001 Oct; 25(4):203-7. PubMed ID: 11599101
[TBL] [Abstract][Full Text] [Related]
18. Cytologic features, immunocytochemical findings, and DNA ploidy in four rare cases of epithelioid hemangioendothelioma involving effusions.
Chen Y; Khanna A; Chen JQ; Zhang HZ; Caraway NP; Katz RL
Cytojournal; 2018; 15():13. PubMed ID: 29937917
[TBL] [Abstract][Full Text] [Related]
19. Effects of the Storage Solution Type and Prolonged Storage on the Immunoreactivity of Cells.
Ikeda K; Sato S; Chigira H; Shibuki Y; Hiraoka N
Acta Cytol; 2020; 64(4):352-359. PubMed ID: 31597129
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three commonly used cytologic preparations in effusion immunocytochemistry.
Fetsch PA; Simsir A; Brosky K; Abati A
Diagn Cytopathol; 2002 Jan; 26(1):61-6. PubMed ID: 11782091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
